| |
Term | Laboratory |
|---|---|---|
| Hideya Sakaguchi | Until Aug 2025 | Neural Organogenesis Research (Special Program) |
| Shigeo Hayashi | Until Mar 2025 | Morphogenetic Signaling |
| Teruki Honma | Until Mar 2025 |
Laboratory for Structure-Based Molecular Design Drug Discovery Computational Chemistry Platform Unit |
| Takamitsu Hosoya | Until Mar 2025 | Chemical Biology |
| Yoshitaka Ishii | Until Mar 2025 | Advanced NMR Application and Development |
| Takuhiro Ito | Until Mar 2025 | Translation Structural Biology |
| Kyogo Kawaguchi | Until Mar 2025 | Nonequilibrium Physics of Living Matter RIKEN Hakubi Research Team |
| Hidetoshi Masumoto | Until Mar 2025 | iPS cell-based Cardiovascular Medical Research |
| Makito Miyazaki | Until Mar 2025 | Bottom-up Cell Biology |
| Ai Niitsu | Until Mar 2025 | Dynamic Biomolecule Design |
| Itoshi Nikaido | Until Mar 2025 | Bioinformatics Research |
| Eisuke Nishida | Until Mar 2025 | Molecular Biology of Aging |
| Shun-Ichi Sekine | Until Mar 2025 |
Transcription Structural Biology Cryo-EM Operation Team |
| Ichio Shimada | Until Mar 2025 |
Dynamic Structure of Biomolecules NMR Operation Team |
| Mikako Shirouzu | Until Mar 2025 |
Protein Functional and Structural Biology Drug Discovery Structural Biology Platform Unit |
| Yuji Sugita | Until Mar 2025 | Biomolecular Function Simulation |
| Shunsuke Tagami | Until Mar 2025 | Advanced Biomolecular Engineering |
| Reiya Taniguchi | Until Mar 2025 | In situ Structural Biology |
| Hiroki Ueda | Until Mar 2025 | Synthetic Biology |
| Masahiro Ueda | Until Mar 2025 | Cell Signaling Dynamics |
| Yoshinori Yanagisawa | Until Mar 2025 | Next-Generation Magnet Development Collaboration Unit |
| Shigenobu Yonemura | Until Mar 2025 | Ultrastructural Research |
| Shigeru Kuratani | Until Mar 2024 | Evolutionary Morphology |
| Takashi Tsuji | Until Mar 2024 | Organ Regeneration |
| Dan Ohtan Wang | Until Mar 2024 | Neuroepitranscriptomics |
| Kenta Sumiyama | Until Sep 2023 | Mouse Genetic Engineering |
| Yi-Long Cui | Until Mar 2023 | Biofunction Dynamics Imaging |
| Hisashi Doi | Until Mar 2023 | Labeling Chemistry |
| Hiroshi Hamada | Until Mar 2023 | Organismal Patterning |
| Atsushi Iriki | Until Mar 2023 | Symbolic Cognitive Development |
| Atsuko Iwane | Until Mar 2023 | Cell Field Structure |
| Takashi Jin | Until Mar 2023 | Nano-Bio Probes |
| Yosky Kataoka | Until Mar 2023 | Cellular Function Imaging |
| Takanori Kigawa | Until Mar 2023 | Cellular Structural Biology |
| Shigehiro Kuraku | Until Mar 2023 | Phyloinformatics |
| Fumio Matsuzaki | Until Mar 2023 | Cell Asymmetry |
| Yuko Mimori-Kiyosue | Until Mar 2023 | Molecular and Cellular Dynamics |
| Kei Mizuno | Until Mar 2023 | Health Estimation (RIKEN BDR-DAIKIN Collaboration Center) |
| Hidefumi Mukai | Until Mar 2023 | Molecular Delivery and Imaging Technology |
| Kensaku Sakamoto | Until Mar 2023 | Nonnatural Amino Acid Technology |
| Yuichi Taniguchi | Until Mar 2023 | Cell Systems Control |
| Takashi Umehara | Until Mar 2023 | Epigenetics Drug Discovery |
| Yasuyoshi Watanabe | Until Mar 2023 |
Pathophysiological and Health Science, Health Solution (RIKEN BDR-DAIKIN Collaboration Center), Next-Generation Imaging |
| Toshio Yamazaki | Until Mar 2023 | NMR Engineering and Structural Science |
| Kam Zhang | Until Mar 2023 | Structural Bioinformatics |
| Yo Tanaka | Until Aug 2022 | Integrated Biodevice |
| Masanori Miyanishi | Until Jun 2022 | Hematopoietic Stem Cell Research (Clinical Translational Research Program) |
| Hidehiko Inomata | Until Mar 2022 | Axial Pattern Dynamics |
| Keiichi Namba | Until Mar 2022 | Supramolecular System Dynamics Research |
| Masatoshi Takeichi | Until Mar 2020 | Cell Adhesion and Tissue Patterning |
| Toshio Yanagida | Until Mar 2020 |
Cell Dynamics Research, Single Cell Mass Spectrometry |
| Masayo Takahashi | Until Jul 2019 | Retinal Regeneration |
| Takashi Nishimura | Until Jun 2019 | Growth Control Signaling |
| Miki Ebisuya | Until Mar 2019 | Reconstitutive Developmental Biology |
| Yasuhide Furuta | Until Mar 2019 | Genetic Engineering |


